Skip to content

Press Release

Previous Article
Next Article

Recent Articles

How UCL Genomics takes on 2000 projects a year
How UCL Genomics takes on 2000 projects a year
The challenge of mapping brain cells tied to central nervous system disorders
The challenge of mapping brain cells tied to central nervous system disorders
Illumina’s statement on the Unreliable Entities List
Illumina’s statement on the Unreliable Entities List
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see www.illumina.com/company/legal.html.

© 2025 Illumina, Inc. All rights reserved.